Why is Anuh Pharma falling/rising?

As of 22-Aug, Anuh Pharma Ltd's stock price is currently at 90.30, reflecting a decrease of 1.2, or 1.31%. The stock has been underperforming, having fallen consecutively for the last two days with a total decline of 1.74%. Despite opening with a gain of 3.21% and reaching an intraday high of Rs 94.44, it ultimately touched a low of Rs 89. The stock's performance over the past week shows a modest increase of 1.98%, but it has significantly underperformed over the past month and year, with declines of 12.33% and 14.37%, respectively. The company's low debt-to-equity ratio and attractive valuation metrics, such as a return on equity of 14.2 and a price-to-book value of 2.8, suggest some underlying strength; however, the stock's profits have decreased by 20.2% over the past year, contributing to its recent price decline.
In the broader market context, Anuh Pharma's recent performance contrasts with the benchmark Sensex, which has shown a positive return of 0.88% over the past week and a 4.05% increase year-to-date. The stock's poor long-term growth prospects, highlighted by an annual operating profit growth rate of only 12.37% over the last five years, further exacerbate its struggles. Additionally, the company has faced negative results, including a significant increase in raw material costs and a low interest coverage ratio, which have negatively impacted investor sentiment. Overall, while there has been some increase in investor participation, the stock's inability to maintain upward momentum amidst these challenges has led to its current downward trajectory.